title: Mutational effects on inclusion body formation in the periplasmic expression of the immunoglobulin VL domain REI.
abstract: BACKGROUND
  Inclusion body (IB) formation in bacteria is an important example of protein misassembly, a phenomenon which also includes folding-dependent aggregation in vitro and amyloid deposition in human disease. Previous studies of mutational effects in other systems implicate the stability of a folding intermediate-rather than the native state-as playing a key role in IB formation. To contribute to an understanding of the comparative biophysics of VL misassembly in different biological settings, we have studied mutation-dependent periplasmic IB formation by the VL domain REI in Escherichia coli.
  
  
  RESULTS
  A series of mutants were produced in periplasmic IBs, where, in all cases, the signal peptide was removed. In addition, the intradomain disulfide was clearly formed before deposition into IBs. IB formation in these mutants does not correlate with monomer/dimer equilibrium constants, but does correlate with the thermodynamic stability of the native state.
  
  
  CONCLUSIONS
  The results implicate a late, equilibrium folding intermediate in IB formation, in contrast to the apparent involvement of transient folding intermediates in other IB systems described to date. As equilibrium unfolding intermediates have also been implicated in light chain amyloidosis and deposition diseases, IB formation may prove a useful model for these human diseases.
authors.affiliation: Department of Macromolecular Sciences, SmithKline Beecham Pharmaceuticals, King of Prussia, PA 19406, USA.
authors.forename: W
authors.initials: W
authors.lastname: Chan
authors.forename: L R
authors.initials: LR
authors.lastname: Helms
authors.forename: I
authors.initials: I
authors.lastname: Brooks
authors.forename: G
authors.initials: G
authors.lastname: Lee
authors.forename: S
authors.initials: S
authors.lastname: Ngola
authors.forename: D
authors.initials: D
authors.lastname: McNulty
authors.forename: B
authors.initials: B
authors.lastname: Maleeff
authors.forename: P
authors.initials: P
authors.lastname: Hensley
authors.forename: R
authors.initials: R
authors.lastname: Wetzel
mesh_terms: D000595:Amino Acid Sequence; D001483:Base Sequence; D004274:DNA, Recombinant / Q000235:genetics; D019281:Dimerization; D004355:Drug Stability; D004926:Escherichia coli / Q000737:chemistry / Q000235:genetics / Q000648:ultrastructure; D015870:Gene Expression; D006801:Humans; D007147:Immunoglobulin Light Chains / Q000737:chemistry / Q000235:genetics* / Q000378:metabolism*; D007135:Immunoglobulin Variable Region / Q000737:chemistry / Q000235:genetics* / Q000378:metabolism*; D002479:Inclusion Bodies / Q000737:chemistry / Q000648:ultrastructure; D008854:Microscopy, Electron; D008958:Models, Molecular; D008969:Molecular Sequence Data; D015394:Molecular Structure; D009154:Mutation; D010446:Peptide Fragments / Q000737:chemistry / Q000235:genetics / Q000378:metabolism; D011487:Protein Conformation; D017510:Protein Folding; D011994:Recombinant Proteins / Q000737:chemistry / Q000235:genetics / Q000378:metabolism; D012995:Solubility; D013816:Thermodynamics
chemical_list: D004274:DNA, Recombinant; D007147:Immunoglobulin Light Chains; D007135:Immunoglobulin Variable Region; D010446:Peptide Fragments; D011994:Recombinant Proteins